Product NDC: | 16590-859 |
Proprietary Name: | EVOXAC |
Non Proprietary Name: | CEVIMELINE HYDROCHLORIDE |
Active Ingredient(s): | 30 mg/1 & nbsp; CEVIMELINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-859 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020989 |
Marketing Category: | NDA |
Start Marketing Date: | 20000111 |
Package NDC: | 16590-859-71 |
Package Description: | 100 CAPSULE in 1 BOTTLE (16590-859-71) |
NDC Code | 16590-859-71 |
Proprietary Name | EVOXAC |
Package Description | 100 CAPSULE in 1 BOTTLE (16590-859-71) |
Product NDC | 16590-859 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CEVIMELINE HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20000111 |
Marketing Category Name | NDA |
Labeler Name | STAT RX USA LLC |
Substance Name | CEVIMELINE HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |